AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BICYCLE THERAPEUTICS PLC Director's Dealing 2025

Sep 10, 2025

32777_dirs_2025-09-10_78adef31-eeba-4c49-9ca4-557f619dd8dd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BICYCLE THERAPEUTICS PLC (BCYC)
CIK: 0001761612
Period of Report: 2025-09-08

Reporting Person: DANSEY ROGER D (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-09-08	Ordinary Shares	A	12500	—	Acquired	12500	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-09-08	Stock Option (right to buy)	$7.16	A	25000	Acquired	2035-09-08	Ordinary Shares (25000)	Direct

Footnotes

F1: Represents a restricted share unit ("RSU") award. The RSUs will vest in three equal installments on each of September 8, 2026, September 8, 2027 and September 8, 2028.

F2: Each RSU represents a contingent right to receive one ordinary share.

F3: This option will vest in three equal installments on each of September 8, 2026, September 8, 2027 and September 8, 2028.